Aplos NCA

Aplos NCA is a cloud-based platform for non-compartmental pharmacokinetic (PK) analysis, designed for pharmaceutical researchers, PK analysts, and academic institutions conducting drug development studies.

Reviewed by 7wData
API Available

On this page

Publisher review

Aplos NCA is a cloud-based platform for non-compartmental pharmacokinetic (PK) analysis, designed for pharmaceutical researchers, PK analysts, and academic institutions conducting drug development studies. The tool provides end-to-end workflows from raw data ingestion to regulatory-compliant reporting, with specific optimizations for handling large-scale PK datasets. Its 21 CFR Part 11 compliance and integrated audit trails cater to regulated environments, while the academic program offers free access (with 10-profile limits) for educational use. Competitors like Certara Phoenix WinNonlin typically require local installation, whereas Aplos NCA's cloud API enables immediate analysis without software deployment.

The platform processes 1.5 million PK profiles in under 5 minutes using 3,000 parallel calculation engines, each handling 500 profiles. It integrates rule-based data cleaning for BLQ values and arithmetic conversions, with customizable templates for tables, figures, and appendices. Users can export results to R, SAS, or GraphPad Prism via API, and the web interface supports SAML SSO for enterprise teams. Regional data isolation meets geographic compliance needs, while private instances ensure team workflow separation. Automated parameter calculations include AUC, Cmax, and Tmax with full traceability from source data.

Compared to legacy tools like WinNonlin or Watson LIMS, Aplos NCA specializes exclusively in non-compartmental analysis, claiming 90% faster processing than manual methods. Its cloud model contrasts with competitors' on-premise solutions, though Sage Intacct and NetSuite offer broader financial analytics suites. The platform lacks compartmental modeling capabilities, focusing instead on high-throughput NCA with validation-ready outputs. Enterprise pricing is opaque, requiring direct consultation, while academic users face strict profile limits per dataset.

Trade-offs include limited support for complex PK/PD modeling beyond NCA, and academic users cannot analyze datasets exceeding 10 profiles. While the Teams plan ($18k/year for 5 users) includes a private instance, larger organizations must negotiate custom enterprise contracts. Some advanced reporting features require additional licensing, and the platform doesn't support non-PK bioanalytical data processing. However, its automated audit trails and version control reduce compliance overhead for GLP environments.

Get the AI & data signal, daily.

335k+ subscribers read this every morning. One email, both newsletters. Unsubscribe anytime.

How it works

  1. Massive parallel processing

    Analyzes 1.5M PK profiles in 5 minutes using 3,000 concurrent engines, each processing 500 profiles

  2. Regulatory compliance

    21 CFR Part 11 validated with end-to-end encryption and electronic audit trails for all data changes

  3. Custom data cleaning

    Rule-based handling of BLQ values and arithmetic conversions integrated into analysis workflows

  4. Multi-platform integration

    API connections to R, SAS, and GraphPad Prism for downstream analysis and visualization

  5. Enterprise security

    SAML SSO and regional data isolation options for geographically distributed teams

  6. Automated reporting

    Generates validation-ready reports with PK parameters, tables, and plots using customizable templates

  7. Academic program

    Free access for academic users with limitations of 10 profiles per dataset analysis

Strengths and trade-offs

Strengths

  • Processes large datasets at scale, analyzing 1.5 million PK profiles in under 5 minutes with parallel computation.
  • Provides 21 CFR Part 11 compliant audit trails and version control for all analytical workflows and data transformations.
  • Offers free academic licensing with core functionality, though limited to 10-profile datasets for instructional use.
  • Integrates with common analysis tools like SAS and R via API, eliminating manual data transfer steps.

Trade-offs

  • Academic version restricts analyses to 10 profiles per dataset, prohibiting large-scale educational research.
  • Enterprise pricing requires direct consultation rather than transparent tiered pricing like the Professional ($4.5k/year) plan.
  • Lacks compartmental modeling capabilities, limiting use to non-compartmental PK analysis workflows.
  • Advanced reporting features like custom web interfaces may require additional licensing beyond base plans.

Pricing context

Professional: $4,500/year (single user); Teams: $18,000/year (5 users); Enterprise: Custom pricing (15+ users)

Getting started with Aplos NCA

  1. Sign up

    Create an account on the Aplos NCA platform. Choose between Professional, Teams, or Enterprise plans based on your organization's needs. Academic users can access the free academic program.

  2. Connect data

    Upload your PK dataset to the platform. Ensure the data is formatted correctly for non-compartmental analysis. Use the API to integrate with tools like R, SAS, or GraphPad Prism if needed.

  3. Configure settings

    Set up rule-based data cleaning for BLQ values and arithmetic conversions. Customize templates for tables, figures, and appendices to match your reporting requirements.

  4. Run analysis

    Initiate the non-compartmental analysis on your dataset. The platform processes data using parallel engines, delivering results in minutes for large-scale PK profiles.

  5. Export results

    Download validation-ready reports with PK parameters, tables, and plots. Use the API to export results to R, SAS, or GraphPad Prism for further analysis or visualization.

Frequently Asked Questions

What is Aplos NCA?

Aplos NCA is a cloud-based platform for non-compartmental pharmacokinetic (PK) analysis, designed for pharmaceutical researchers and academic institutions. It offers end-to-end workflows from data ingestion to regulatory-compliant reporting, optimized for large-scale PK datasets.

How much does Aplos NCA cost?

Aplos NCA offers tiered pricing: Professional plan at $4,500/year for single users, Teams plan at $18,000/year for five users, and custom Enterprise pricing for organizations with 15+ users. Academic users can access the platform for free with a 10-profile limit per dataset.

Is Aplos NCA suitable for academic use?

Yes, Aplos NCA provides free access for academic users, though with limitations. Academic licenses allow analysis of datasets with up to 10 profiles, making it suitable for educational purposes but restrictive for large-scale research.

Does Aplos NCA comply with regulatory standards?

Aplos NCA is fully compliant with 21 CFR Part 11, featuring end-to-end encryption, electronic audit trails, and version control. These features ensure data integrity and traceability, making it suitable for regulated environments in pharmaceutical research.

How fast is Aplos NCA for PK analysis?

Aplos NCA processes 1.5 million PK profiles in under 5 minutes using 3,000 parallel calculation engines. This high-throughput capability makes it 90% faster than manual methods, ideal for large-scale pharmacokinetic studies.

What are the limitations of Aplos NCA?

Aplos NCA lacks compartmental modeling capabilities, focusing solely on non-compartmental PK analysis. Academic users face a 10-profile limit per dataset, and enterprise pricing requires direct consultation. Advanced reporting features may also require additional licensing beyond base plans.

Alternatives

How Aplos NCA compares

Direct head-to-head against 2 competitors. Picked by 7wData.

This tool

Aplos NCA

Pricing
Professional: $4,500/year (single user); Teams: $18,000/year (5 users); Enterprise: Custom pricing (15+ users)
Target
Aplos NCA is a cloud-based platform for non-compartmental pharmacokinetic (PK) analysis, designed for pharmaceutical researchers, PK analysts, and academic institutions conducting drug development studies.
Strength
Processes large datasets at scale, analyzing 1.5 million PK profiles in under 5 minutes with parallel computation.
Watch for
Academic version restricts analyses to 10 profiles per dataset, prohibiting large-scale educational research.

Phoenix WinNonlin

Pricing
Custom/Contact sales
Target
Enterprise pharma PK/PD teams
Deployment
Windows desktop
Strength
Industry standard with FDA validation
Watch for
Legacy desktop architecture

SAS Pharmaceutical

Pricing
$8,700+/year per user
Target
Regulated clinical research
Deployment
On-prem/cloud
Strength
End-to-end clinical analytics
Watch for
Steep learning curve

User reviews

No user reviews yet. Be the first to write one.

Sources

Reporting on this tool draws on these publicly available sources.

  1. aplosanalytics.com
  2. aplosanalytics.com
  3. www.bioanalysis-zone.com
  4. www.linkedin.com